Topics

Antiviral drugmakers GSK, Gilead join fight against coronavirus' spread

06:50 EST 3 Feb 2020 | BioPharmaDive

Gilead will work with Chinese authorities to test its drug remdesivir in a randomized study, while GSK is providing its adjuvant platforms to groups partnered with CEPI.

Original Article: Antiviral drugmakers GSK, Gilead join fight against coronavirus' spread

NEXT ARTICLE

More From BioPortfolio on "Antiviral drugmakers GSK, Gilead join fight against coronavirus' spread"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...